Trospium / Xanomeline and Bosutinib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Bosutinib
Trospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Cobenfy contains xanomeline, which can briefly slow down an enzyme in your gut called CYP3A4. Your leukemia medicine, bosutinib (Bosulif), is broken down by that same enzyme when it's absorbed. So when you take them together, a little more bosutinib may get into your body than usual.
More bosutinib can mean more of its usual side effects, like diarrhea, nausea, or stomach upset. The good news is this is a theoretical concern, meaning it's based on how the drugs work rather than reports of harm. Your care team can easily keep an eye on you and adjust things if needed. Let them know you take both.
Mechanism: Xanomeline (in Cobenfy) transiently inhibits intestinal CYP3A4 without meaningful systemic inhibition. Bosutinib is a sensitive oral CYP3A4 substrate (not a prodrug), so reduced first-pass metabolism may raise its exposure (AUC/Cmax).
Direction: Increased bosutinib exposure, potentially increasing frequency/severity of dose-related adverse effects (GI toxicity, myelosuppression, hepatotoxicity, QT effects).
- Severity: Moderate
- Onset: Unspecified
- Evidence: Theoretical
Management: Monitor for enhanced bosutinib-related adverse reactions. Dose may need individualization by the oncology team; consider closer clinical and lab monitoring if co-prescribed.
What happens
Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions
Interaction Deep Dive
Within the gut, xanomeline produces a temporary, local inhibition of CYP3A4, though this effect does not extend systemically. When xanomeline is taken together with oral medications that are sensitive CYP3A4 substrates, the exposure to those oral sensitive CYP3A4 substrates may rise. Such an increase can lead to a greater frequency and/or severity of adverse reactions from these substrates. Should the two be used together, watch patients for any rise in the frequency and/or severity of adverse reactions associated with oral drugs that are sensitive CYP3A4 substrates1.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by xanomeline
How to manage this interaction
Keep taking both medicines as prescribed unless your care team tells you otherwise. This interaction is theoretical, and it can be managed with awareness and monitoring.
- Tell your pharmacist and oncologist that you take both Bosulif and Cobenfy.
- Watch for stronger bosutinib side effects, such as diarrhea, nausea, vomiting, belly pain, or feeling unusually tired.
- Your team may check on you more closely or tailor your bosutinib dose if needed.
- Report any new or worsening symptoms rather than changing doses on your own.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Trospium / Xanomeline and Bosutinib together?
Cobenfy (xanomeline) may modestly raise bosutinib levels by slowing its breakdown in the gut, which could increase bosutinib side effects. This is a theoretical concern that your care team can manage by monitoring you and adjusting the dose if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Trospium / Xanomeline and Bosutinib interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Trospium / Xanomeline and Bosutinib interaction managed?
Keep taking both medicines as prescribed unless your care team tells you otherwise. This interaction is theoretical, and it can be managed with awareness and monitoring. Tell your pharmacist and oncologist that you take both Bosulif and Cobenfy. Watch for stronger bosutinib side effects, such as diarrhea, nausea, vomiting, belly pain, or feeling unusually tired. Your team may check on you more clo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Trospium / Xanomeline or Bosutinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Citation #1
Keep reading about Bosutinib
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist